The Valley Desk

NCT00215540 · Interventional trial

SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.

Overall registry status Terminated

Phase 2

Conditions Bronchopulmonary Dysplasia, Premature Birth, Respiratory Distress Syndrome, Newborn

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov